AU2001230525A1 - Sulfate salt of quinolonecarboxylic acid derivative and use thereof - Google Patents

Sulfate salt of quinolonecarboxylic acid derivative and use thereof

Info

Publication number
AU2001230525A1
AU2001230525A1 AU2001230525A AU3052501A AU2001230525A1 AU 2001230525 A1 AU2001230525 A1 AU 2001230525A1 AU 2001230525 A AU2001230525 A AU 2001230525A AU 3052501 A AU3052501 A AU 3052501A AU 2001230525 A1 AU2001230525 A1 AU 2001230525A1
Authority
AU
Australia
Prior art keywords
acid derivative
sulfate salt
quinolonecarboxylic acid
sulfate
dihydr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001230525A
Other languages
English (en)
Inventor
Yasuhiro Aizawa
Tomomi Koike
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Publication of AU2001230525A1 publication Critical patent/AU2001230525A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
AU2001230525A 2000-02-01 2001-01-30 Sulfate salt of quinolonecarboxylic acid derivative and use thereof Abandoned AU2001230525A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-23609 2000-02-01
JP2000023609 2000-02-01
PCT/JP2001/000599 WO2001057017A1 (fr) 2000-02-01 2001-01-30 Sel de sulfate de quinolone d'acide carboxylique et son utilisation

Publications (1)

Publication Number Publication Date
AU2001230525A1 true AU2001230525A1 (en) 2001-08-14

Family

ID=18549738

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001230525A Abandoned AU2001230525A1 (en) 2000-02-01 2001-01-30 Sulfate salt of quinolonecarboxylic acid derivative and use thereof

Country Status (8)

Country Link
US (1) US6582609B2 (de)
EP (1) EP1253149B1 (de)
AT (1) ATE372997T1 (de)
AU (1) AU2001230525A1 (de)
CA (1) CA2399516A1 (de)
DE (1) DE60130429D1 (de)
TW (1) TWI225057B (de)
WO (1) WO2001057017A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7882081B2 (en) * 2002-08-30 2011-02-01 Netapp, Inc. Optimized disk repository for the storage and retrieval of mostly sequential data
WO2004101547A1 (en) * 2003-05-19 2004-11-25 Hetero Drugs Limited Purification methods of gatifloxacin and a novel form of gatifloxacin
US7459289B2 (en) 2004-03-08 2008-12-02 North Carolina State University Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
CN1019114B (zh) 1986-03-31 1992-11-18 三共株式会社 喹啉-3-羟酸衍生物的制备方法
JPS63198664A (ja) * 1986-03-31 1988-08-17 Sankyo Co Ltd キノロンカルボン酸誘導体
JPH11209286A (ja) 1998-01-21 1999-08-03 Kyorin Pharmaceut Co Ltd ガチフロキサシンを有効成分とする抗Ｈ．ｐｙｌｏｒｉ剤
EP1025846B1 (de) 1998-08-21 2006-07-12 Senju Pharmaceutical Co., Ltd. Wässerige flüssige zubereitungen
CN1257073A (zh) 1998-12-11 2000-06-21 国家医药管理局上海医药工业研究院 1－环丙基－6－氟－7－(3－甲基哌嗪－1－基)－8－甲氧基－1,4－二氢－4－氧代喹啉－3－羧酸及其盐和它们的制备方法

Also Published As

Publication number Publication date
CA2399516A1 (en) 2001-08-09
US6582609B2 (en) 2003-06-24
EP1253149A1 (de) 2002-10-30
ATE372997T1 (de) 2007-09-15
DE60130429D1 (de) 2007-10-25
TWI225057B (en) 2004-12-11
US20030013882A1 (en) 2003-01-16
EP1253149A4 (de) 2003-04-16
WO2001057017A1 (fr) 2001-08-09
EP1253149B1 (de) 2007-09-12

Similar Documents

Publication Publication Date Title
AU2002224927A1 (en) Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
EP1442028A4 (de) Substituierte säurederivate, die sich als antidiabetika und mittel gegen obesitas eignen, und verfahren
IL214164A0 (en) Process for the preparation of intermediates useful in the synthesis of statin derivatives especially 7-amino 3,5-dihydroxy heptanoic acid derivatives, and intermediates thereof
AU2002223058A1 (en) Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peeling
PL366401A1 (en) Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc.
AU2001290245A1 (en) Aqueous solution of aminated silanol compound, use thereof, and process for producing the same
AU2002233928A1 (en) Cycloalkylfused (g)-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
AU2001226794A1 (en) Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
AU2002227015A1 (en) Processes and synthetic intermediates for preparing N-arylacridancarboxylic acid derivatives
AU2002220735A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
GB0103111D0 (en) Treatment of fibromyalgia with ubiquinone 10 or succinic acid
AU2002361889A1 (en) Infrared sensing of concentration of methanol's aqueous solution
EP1298131A4 (de) Derivate der chinoloncarbonsäure
AU2001244671A1 (en) Quinolonecarboxylic acid derivative
AU2001230525A1 (en) Sulfate salt of quinolonecarboxylic acid derivative and use thereof
AU2001286852A1 (en) Quinoline antibacterial compounds and methods of use thereof
TWI264435B (en) Intermediates for the production of quinoline carboxylic acid derivatives
AU1304701A (en) Alkali metal salts of quinolinecarboxylic acid derivatives and process for purifying quinoline-carboxylic acid derivatives by using the salts
HUP0401746A3 (en) Substituted 6-(2-tolyl)-triazolopyrimidines as fungicides
AU6868700A (en) Quinolinecarboxylic acid derivative or its salt
AU2002365511A1 (en) Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23
AU2001244122A1 (en) Process for preparing piperazic acid derivatives thereof
HUP0700056A3 (en) Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
AU2001252254A1 (en) 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparationthereof and use thereof
AU2002213878A1 (en) Use of erythropoietin and the derivatives of the same for treating schizophrenia and related psychoses